Alan Heaton

804 total citations
17 papers, 633 citations indexed

About

Alan Heaton is a scholar working on Geriatrics and Gerontology, Family Practice and Economics and Econometrics. According to data from OpenAlex, Alan Heaton has authored 17 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 7 papers in Family Practice and 6 papers in Economics and Econometrics. Recurrent topics in Alan Heaton's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Medication Adherence and Compliance (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Alan Heaton is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Medication Adherence and Compliance (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Alan Heaton collaborates with scholars based in United States and China. Alan Heaton's co-authors include Stephen W. Schondelmeyer, Brian J. Isetts, Margaret B. Artz, Lawrence M. Brown, Robert J. Cipolle, Patrick P. Gleason, Jeremy A Schafer, Catherine I. Starner, Bryan Dowd and Amer Kaissi and has published in prestigious journals such as The American Journal of Medicine, Medical Care and Journal of General Internal Medicine.

In The Last Decade

Alan Heaton

17 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Heaton United States	11	362	203	176	152	107	17	633
J. Lars G. Nilsson Sweden	18	313 0.9×	343 1.7×	151 0.9×	142 0.9×	168 1.6×	33	897
Robert Dombrowski United States	10	326 0.9×	151 0.7×	199 1.1×	83 0.5×	70 0.7×	12	473
Jannet M. Carmichael United States	13	469 1.3×	167 0.8×	225 1.3×	122 0.8×	107 1.0×	35	607
Brian J. Isetts United States	12	642 1.8×	286 1.4×	211 1.2×	220 1.4×	120 1.1×	36	760
Amanda Brummel United States	12	652 1.8×	342 1.7×	219 1.2×	188 1.2×	119 1.1×	23	758
Troy Trygstad United States	14	294 0.8×	188 0.9×	177 1.0×	211 1.4×	51 0.5×	28	564
Joy Meier United States	9	234 0.6×	140 0.7×	84 0.5×	71 0.5×	55 0.5×	16	504
Hae Mi Choe United States	15	337 0.9×	171 0.8×	145 0.8×	158 1.0×	67 0.6×	48	729
Catherine E. Cooke United States	16	150 0.4×	151 0.7×	122 0.7×	116 0.8×	66 0.6×	57	778
Barry L. Carter United States	9	291 0.8×	185 0.9×	183 1.0×	68 0.4×	58 0.5×	11	486

Countries citing papers authored by Alan Heaton

Since Specialization

Citations

This map shows the geographic impact of Alan Heaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Heaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Heaton more than expected).

Fields of papers citing papers by Alan Heaton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Heaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Heaton. The network helps show where Alan Heaton may publish in the future.

Co-authorship network of co-authors of Alan Heaton

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Heaton. A scholar is included among the top collaborators of Alan Heaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Heaton. Alan Heaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Shrank, William H., Patrick P. Gleason, Claire Canning, et al.. (2009). Can Improved Prescription Medication Labeling Influence Adherence to Chronic Medications? An Evaluation of the Target Pharmacy Label. Journal of General Internal Medicine. 24(5). 570–578. 28 indexed citations

Shrank, William H., Amanda R. Patrick, Patrick P. Gleason, et al.. (2009). An Evaluation of the Relationship Between the Implementation of a Newly Designed Prescription Drug Label at Target Pharmacies and Health Outcomes. Medical Care. 47(9). 1031–1035. 17 indexed citations

Rodin, Holly, et al.. (2009). Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.. PubMed. 15(12). 881–8. 17 indexed citations

Isetts, Brian J., Stephen W. Schondelmeyer, Margaret B. Artz, et al.. (2008). Clinical and economic outcomes of medication therapy management services: The Minnesota experience. Journal of the American Pharmacists Association. 48(2). 203–214. 304 indexed citations

Starner, Catherine I., Jeremy A Schafer, Alan Heaton, & Patrick P. Gleason. (2008). Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events. Journal of Managed Care Pharmacy. 14(6). 523–531. 84 indexed citations

Gunderson, Brent W., et al.. (2007). Utilization, Cost Trends, and Member Cost - Share for Self-Injectable Multiple Sclerosis Drugs-Pharmacy and Medical Benefit Spending From 2004 Through 2007. Journal of Managed Care Pharmacy. 13(9). 799–806. 14 indexed citations

Zhang, Dongmu, Patrick P. Gleason, Stephen W. Schondelmeyer, et al.. (2007). Relationship of the Magnitude of Member Cost-Share and Medication Persistence With Newly Initiated Renin Angiotensin System Blockers. Journal of Managed Care Pharmacy. 13(8). 664–676. 7 indexed citations

Kaissi, Amer, John E. Kralewski, Bryan Dowd, & Alan Heaton. (2007). The effect of the fit between organizational culture and structure on medication errors in medical group practices. Health Care Management Review. 32(1). 12–21. 21 indexed citations

Gleason, Patrick P., et al.. (2007). Telithromycin: The Perils of Hasty Adoption and Persistence of Off-Label Prescribing. Journal of Managed Care Pharmacy. 13(5). 420–425. 29 indexed citations

10.

Isetts, Brian J., et al.. (2006). Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Research in Social and Administrative Pharmacy. 2(1). 129–142. 23 indexed citations

11.

Kralewski, John E., Bryan Dowd, Alan Heaton, & Amer Kaissi. (2005). The Influence of the Structure and Culture of Medical Group Practices on Prescription Drug Errors. Medical Care. 43(8). 817–825. 30 indexed citations

12.

Heaton, Alan, Steve Martin, & Tim Brelje. (2003). The economic effect of hypoglycemia in a health plan.. PubMed. 16(7). 23–7. 35 indexed citations

13.

Heaton, Alan. (2002). High Frequency of Itraconazole Prescriptions with Potentially Interacting Medications in a Large Health Care Plan. Journal of Managed Care Pharmacy. 8(3). 199–203. 7 indexed citations

14.

Gagnon, Jean Paul, Donna Rindress, Patricia A. Deverka, et al.. (1999). Pharmacoeconomics: Identifying the Issues Overview and Advisory Panel Report Summary. Value in Health. 2(2). 67–72. 3 indexed citations

15.

Heaton, Alan, et al.. (1999). Improving the care of hemophiliacs by managing the drug benefit. American Journal of Health-System Pharmacy. 56(13). 1303–1305. 1 indexed citations

16.

Heaton, Alan, et al.. (1996). Cost effectiveness of risk reduction: the managed care perspective. The American Journal of Medicine. 101(4). 71S–75S. 8 indexed citations

17.

Cisternas, Miriam G., et al.. (1996). Economic Implications of Self-treatment of Heartburn/Nonulcur Dyspepsia with Nonprescription Famotidine in a Managed Care Setting. Journal of Managed Care Pharmacy. 2(3). 263–271. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact